Literature DB >> 2479773

Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus.

D Brunner1, N C Pedersen.   

Abstract

Macrophages were harvested from the peritoneal cavities of healthy specific-pathogen-free cats by saline lavage. Three days before collection, the peritoneal cavities were stimulated with glutaraldehyde-fixed Saccharomyces cerevisiae cells to induce greater numbers of macrophages and to begin the activation sequence. Peritoneal macrophages from cats stimulated once with yeast consisted mainly of small macrophages and a smaller number of larger activated macrophages. After several days in culture, many of the small macrophages became activated and a portion of the activated macrophages developed into multinucleated giant cells. Peritoneal cells from cats that were stimulated twice or three times with yeast at 3-week intervals consisted of a higher proportion of activated macrophages initially and produced more and larger multinuclear giant cells with time. Cultures of peritoneal cells stimulated once with yeast were easily infected in vitro with feline immunodeficiency virus (FIV) and produced a transient burst of reverse transcriptase activity. After the initial burst of virus replication, the infection became latent. Even more multinucleated giant cells appeared after infection, and many of these cells fused with each other. Replicating virus could be rescued from the latently infected macrophages after 2 to 3 weeks of phorbol myristate acetate stimulation and cocultivation with T-lymphocyte-enriched peripheral blood mononuclear cells. Multiply stimulated peritoneal cells, which contained a much higher proportion of activated macrophages, could also be infected in vitro with FIV. The infection usually became latent, however, without going through an initial replicative stage. Peritoneal cells from chronically FIV-infected specific-pathogen-free cats contained a higher proportion of activated macrophages and were latently infected with FIV from the outset.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479773      PMCID: PMC251221     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

Authors:  C J Sherr; C W Rettenmier; R Sacca; M F Roussel; A T Look; E R Stanley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

2.  Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages.

Authors:  O Narayan; S Kennedy-Stoskopf; D Sheffer; D E Griffin; J E Clements
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

3.  Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission.

Authors:  J K Yamamoto; H Hansen; E W Ho; T Y Morishita; T Okuda; T R Sawa; R M Nakamura; N C Pedersen
Journal:  J Am Vet Med Assoc       Date:  1989-01-15       Impact factor: 1.936

Review 4.  HIV persistence in monocytes leads to pathogenesis and AIDS.

Authors:  C D Pauza
Journal:  Cell Immunol       Date:  1988-04-01       Impact factor: 4.868

5.  Nucleotide sequence and genomic organization of feline immunodeficiency virus.

Authors:  R L Talbott; E E Sparger; K M Lovelace; W M Fitch; N C Pedersen; P A Luciw; J H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow.

Authors:  H E Gendelman; O Narayan; S Molineaux; J E Clements; Z Ghotbi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.

Authors:  G E Griffin; K Leung; T M Folks; S Kunkel; G J Nabel
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

8.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.

Authors:  H E Gendelman; J M Orenstein; M A Martin; C Ferrua; R Mitra; T Phipps; L A Wahl; H C Lane; A S Fauci; D S Burke
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

9.  Isolation and identification of feline peritoneal macrophages for in vitro studies of coronavirus-macrophage interactions.

Authors:  C A Stoddart; F W Scott
Journal:  J Leukoc Biol       Date:  1988-11       Impact factor: 4.962

10.  Determinants of susceptibility and resistance to feline leukemia virus infection. I. Role of macrophages.

Authors:  E A Hoover; J L Rojko; P L Wilson; R G Olsen
Journal:  J Natl Cancer Inst       Date:  1981-10       Impact factor: 13.506

View more
  55 in total

Review 1.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Authors:  Rick B Meeker; Winona Poulton; Wen-hai Feng; Lola Hudson; Frank M Longo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-10       Impact factor: 4.147

3.  Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses.

Authors:  Mariko Kohmoto; Yasuhiro Ikeda; Eiji Sato; Yorihiro Nishimura; Yasuo Inoshima; Masayuki Shimojima; Yukinobu Tohya; Takeshi Mikami; Takayuki Miyazawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

4.  The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes.

Authors:  K Tomonaga; T Miyazawa; J Sakuragi; T Mori; A Adachi; T Mikami
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

5.  In vivo lymphocyte tropism of feline immunodeficiency virus.

Authors:  R V English; C M Johnson; D H Gebhard; M B Tompkins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

Review 6.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation.

Authors:  E B Stephens; E Monck; K Reppas; E J Butfiloski
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.

Authors:  T Toyosaki; T Miyazawa; T Furuya; K Tomonaga; Y S Shin; M Okita; Y Kawaguchi; C Kai; S Mori; T Mikami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 9.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

10.  A detailed phylogenetic analysis of FIV in the United States.

Authors:  Eric A Weaver
Journal:  PLoS One       Date:  2010-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.